On the other hand, T2DM is often associated with increased body mass index (BMI), and other studies have suggested that levels of plasma DPP-4 activity actually correlate better with clinical parameters of obesity rather than of T2DM and glucose per se. This evidence concerns the gene DPP4 and obesity due to melanocortin 4 receptor deficiency.